Cash and cash equivalents (USD, millions)

Restricted cash and cash equivalents (USD, millions)

Default funds and margin deposits – Assets (USD, millions)

Financial investments (USD, millions)

Receivables, net (USD, millions)

Other current assets (USD, millions)

Total current assets (USD, millions)

Property and equipment, net (USD, millions)

Goodwill (USD, millions)

Intangible assets, net (USD, millions)

Operating lease assets (USD, millions)

Other non‐current assets (USD, millions)

Total assets (USD, millions)

Accounts payable and accrued expenses (USD, millions)

Section 31 fees payable to SEC (USD, millions)

Accrued personnel costs (USD, millions)

Deferred revenue (USD, millions)

Other current liabilities (USD, millions)

Default funds and margin deposits – Liabilities (USD, millions)

Short‐term debt (USD, millions)

Total current liabilities (USD, millions)

Long‐term debt (USD, millions)

Deferred tax liabilities, net (USD, millions)

Operating lease liabilities (USD, millions)

Other non‐current liabilities (USD, millions)

Total liabilities (USD, millions)

Common stock (USD, millions)

Additional paid‐in capital (USD, millions)

Common stock in treasury, at cost (USD, millions)

Accumulated other comprehensive loss (USD, millions)

Retained earnings (USD, millions)

Total Nasdaq stockholders’ equity (USD, millions)

Noncontrolling interests (USD, millions)

Total equity (USD, millions)

Total liabilities and equity (USD, millions)

10714a3cb2c49c7672260c1261be94eb4eb2e42cbf5741083d6e6b8e19d85209

Total Revenues (USD, millions)

Transaction Rebates (USD, millions)

Brokerage, Clearance and Exchange Fees (USD, millions)

Revenues Less Transaction-Based Expenses (USD, millions)

Compensation and Benefits (USD, millions)

Professional and Contract Services (USD, millions)

Technology and Communication Infrastructure (USD, millions)

Occupancy (USD, millions)

General, Administrative and Other (USD, millions)

Marketing and Advertising (USD, millions)

Depreciation and Amortization (USD, millions)

Regulatory (USD, millions)

Merger and Strategic Initiatives (USD, millions)

Restructuring Charges (USD, millions)

Total Operating Expenses (USD, millions)

Operating Income (USD, millions)

Interest Income (USD, millions)

Interest Expense (USD, millions)

Other income (loss) (USD, millions)

Net Income (Loss) from Unconsolidated Investees (USD, millions)

Income Before Income Taxes (USD, millions)

Income Tax Provision (USD, millions)

Net Income (USD, millions)

Net Loss Attributable to Noncontrolling Interests (USD, millions)

Net Income Attributable to Nasdaq (USD, millions)

9465c0457c047fbf0f23c4c8b9b016f779b71495da88f8cc5ab4d2e5ae463553

Net income (USD, millions)

Depreciation and amortization (USD, millions)

Share-based compensation (USD, millions)

Net (income) loss from unconsolidated investees (USD, millions)

Other reconciling items included in net income (USD, millions)

Net cash provided by operating activities (USD, millions)

Purchases of securities (USD, millions)

Proceeds from sales and redemptions of securities (USD, millions)

Purchases of property and equipment (USD, millions)

Investments related to default funds and margin deposits, net (USD, millions)

Other investing activities (USD, millions)

Net cash provided by (used in) investing activities (USD, millions)

Repayments of commercial paper, net (USD, millions)

Repurchases of common stock (USD, millions)

Dividends paid (USD, millions)

Payments related to employee shares withheld for taxes (USD, millions)

Other financing activities (USD, millions)

Net cash provided by (used in) financing activities (USD, millions)

Effect of exchange rate changes on cash and cash equivalents and restricted cash and cash equivalents (USD, millions)

Net increase (decrease) in cash and cash equivalents and restricted cash and cash equivalents (USD, millions)

Interest paid (USD, millions)

Income taxes paid, net of refund (USD, millions)

Deferred income taxes (USD, millions)

Cash and cash equivalents, restricted cash and cash equivalents at beginning of period (USD, millions)

Cash and cash equivalents, restricted cash and cash equivalents at end of period (USD, millions)

6d485ecd3a511c9a30a5162e8122183af743661557a7c189a6e548dae68f49d0

Adjustments for Non-Cash Items [USD, Millions]

Stock-Based Compensation [USD, Millions]

Changes in Working Capital [USD, Millions]

Capital Expenditures (CapEx) [USD, Millions]

Proceeds from / Repayments of Debt [USD, Millions]

Share Repurchases [USD, Millions]

Dividend Payments [USD, Millions]

Net Change in Cash [USD, Millions]

3b8ceda5eca4d89a2d7f2ab8d112bf3870c4947476f7bbcebd016ea71cf7a048

c6d0b963ec2f04cb993262e879899e0b5ad17eedf67b3acde0d85f5fde02f52e

Total Revenue [USD, Millions]

Cost of Goods Sold (COGS) [USD, Millions]

SG&A [USD, Millions]

R&D [USD, Millions]

D&A [USD, Millions]

Interest Expense [USD, Millions]

Operating Income (EBIT) [USD, Millions]

Net Income [USD, Millions]

EPS - Basic [USD]

EPS - Diluted [USD]

d9ca3f3ce1d41f669218ea5d353435d395c908d967cb58268cb464c7b3fddc25

00f9e53d571bf6e03fde0b6d6daa23da9f3b239cd585de5ea4d928b9579bae9f

7d72d84830558bfbd6049fb41c708b549617a5381c0b22094c4b689c799851e3

United States

All other countries

Total Revenue

8b9ac3998c8f88246c0f58bb1f4f5d8de18b3ee3c13b6cc9911b5c8900810441

NASDAQ (NDAQ)

Financials